Role of 18F-FDG PET/CT in detection of disease burden and response assessment in patients with myeloid sarcoma

Conclusion MS are usually associated with significant undiagnosed extra-medullary disease. Thus, 18F-FDG PET/CT should be routinely considered for estimation of actual disease burden in these patients. Also, this modality can serve as a basis for the treatment response assessment in these patients after completion of therapy.

Source: Journal of Nuclear Medicine - May 23, 2018 Category: Nuclear Medicine Authors: Harish, N., Bakhshi, S., Patel, C., Sharma, A., Gupta, R., Sharma, A., Bal, C., Kumar, R. Tags: Pediatrics Posters Source Type: research